George Yancopoulos is co-founder and chief scientific officer of Regeneron, a US biotech that is one of over 80 companies ...

So to find out, I've gone straight to the source. My guest today is Dr. George Yancopoulos. He's the President and Chief Scientific Officer of Regeneron. Dr. Yancopoulos, thanks for joining me.

The tariff actions, which could upend nearly $2.2 trillion in two-way annual U.S. trade, went live hours after Trump declared that all three countries had failed to do enough to stem the flow of ...

Joining me on today's call are Dr. Leonard Schleifer, Board Co-Chair, Co-Founder, President and Chief Executive Officer; Dr. George Yancopoulos, Board Co-Chair, Co-Founder, President, and Chief ...

Maya Ajmera, President & CEO of the Society for Science and Publisher of Science News, chatted with George Yancopoulos, an alumnus and one of the top winners of the 1976 Science Talent Search.

George Yancopoulos. Additionally, Regeneron (REGN) and Sanofi (SNY) updated investors on their Phase 3 program for Dupixent ...

George Yancopoulos, Regeneron Laboratories president and chief scientific officer, took ninth place in the competition in 1976, and went on to become a billionaire in pharmaceutical research, ...

Vagelos will stay in his post until his current term comes to an end on 9th June, but won’t seek re-election, In an unusual move, Regeneron co-founders Leonard Schleifer and George Yancopoulos ...

With this approach the scientists succeeded in precisely exchanging 6 Mb of mouse DNA with the human counterpart, according to George Yancopoulos, chief scientific officer at Regeneron.